Nerve growth factor (NGF) is a key element of inflammatory pain. It induces hyperalgesia by up-regulating the transcription of genes encoding receptors, ion channels, and neuropeptides. Acid-sensing ion channel 3 (ASIC3), a depolarizing sodium channel gated by protons during tissue acidosis, is specifically expressed in sensory neurons. It has been associated to cardiac ischemic and inflammatory pains. We previously showed that low endogenous NGF was responsible for ASIC3 basal expression and high NGF during inflammation increased ASIC3 expression parallely to the development of neuron hyperexcitability associated with hyperalgesia. NGF is known to activate numerous signaling pathways through trkA and p75 receptors. We now show that (i) NGF controls ASIC3 basal expression through constitutive activation of a trkA/phospholipase C/protein kinase C pathway, (ii) high inflammatory-like NGF induces ASIC3 overexpression through a trkA/JNK/ p38MAPK pathway and a p75-dependent mechanism as a transcriptional switch, and (iii) NGF acts through AP1 response elements in ASIC3 encoding gene promoter. These new data indicate potential targets that could be used to develop new treatments against inflammatory pain.
Nerve growth factor (NGF) is a key element of inflammatory pain. It induces hyperalgesia by up-regulating the transcription of genes encoding receptors, ion channels, and neuropeptides. Acid-sensing ion channel 3 (ASIC3), a depolarizing sodium channel gated by protons during tissue acidosis, is specifically expressed in sensory neurons. It has been associated to cardiac ischemic and inflammatory pains. We previously showed that low endogenous NGF was responsible for ASIC3 basal expression and high NGF during inflammation increased ASIC3 expression parallely to the development of neuron hyperexcitability associated with hyperalgesia. NGF is known to activate numerous signaling pathways through trkA and p75 receptors. We now show that (i) NGF controls ASIC3 basal expression through constitutive activation of a trkA/phospholipase C/protein kinase C pathway, (ii) high inflammatory-like NGF induces ASIC3 overexpression through a trkA/JNK/ p38MAPK pathway and a p75-dependent mechanism as a transcriptional switch, and (iii) NGF acts through AP1 response elements in ASIC3 encoding gene promoter. These new data indicate potential targets that could be used to develop new treatments against inflammatory pain.
Inflammation is a major source of pain characterized by spontaneity of painful sensations and hypersensitivity. Among proinflammatory mediators, nerve growth factor (NGF) 1 is a key signal in inflammatory pain (1) (2) (3) (4) . It induces lasting sensitization of sensory neurons by changing transcription levels of pain genes such as the genes coding for preprotachykinin A (precursor of substance P), calcitonin gene-related peptide (5) , tetrodotoxin-resistant voltage-dependent sodium channels (6, 7) , and acid-sensing ion channels (ASICs) (8, 9) . These changes generate neuronal hypersensitivity and spontaneous activity known as peripheral sensitization. Moreover, NGF induces changes at the dorsal horn neuron level and then central sensitization. This potentiation of the sensory tract leads to hyperalgesia (i.e. enhanced responses to noxious stimuli) and allodynia (i.e. innocuous stimuli produce pain), thus producing clinical pain (10) .
During inflammation, extracellular pH drops to values below pH 6 (11, 12) due to the leak of intracellular contents, hypoxic metabolism, and related lactic acid production. Acidosis is an important source of pain. In humans it produces non-adapting nociceptor excitation (13) and contributes to hyperalgesia and allodynia in inflammation (14 -16) . Protons directly activate nociceptors (17) by gating depolarizing cationic channels (18, 19) corresponding to the ASICs (20, 21) . ASICs are sodium channels belonging to the ENaC/DEG family and six isoforms (ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4) have been isolated that associate to form functional homo-or heterotetramers (22) (23) (24) (25) (26) (27) (28) (29) . Among these, ASIC3 is a serious candidate as a pain sensor. First, ASIC3 is specific to dorsal root ganglia (DRG) neurons and is expressed by nociceptors (9) . Second, ASIC3 displays a biphasic current with a fast activated/inactivated transient depolarization followed by a plateau phase (25, 30) , which could account for the sustained feeling of acidic pain. Third, ASIC3 current matches the acid-gated current in cardiac ischemia-sensing neurons and has thus been proposed to be the sensor of painful myocardial acidity (31). Fourth, ASIC3 expression level increases during inflammation in parallel with neuron hyperexcitability, a main characteristic of hyperalgesia (8) . Fifth, the ASIC3 channel is directly inhibited by therapeutic doses of non-steroidal anti-inflammatory drugs like aspirin and diclofenac (9) . Sixth, ASIC3 deficient mice display alterations in the modulation of high intensity pain stimuli (32) .
NGF is one of the major mediators that drive inflammatory sensitization. It can have short term effects on nociceptor sensitization, mainly through phosphorylations that are independent of any transcriptional events. This is the case for TRPV1, the heat/proton-activated cation channel, which is not modulated transcriptionally by inflammatory NGF but via posttranscriptional mechanisms (8, 9, 33, 34) . But the effect of NGF is mainly through phenotypic changes in sensory neurons, modulating gene expression. This is the case for ASIC3 encoding gene regulation (8) .
This paper reports how NGF present at basal concentration is responsible for ASIC3 expression in sensory neurons and how during inflammation high NGF concentrations induce an overexpression of ASIC3 that can account for neuronal hyperexcitability and hyperalgesia. The molecular mechanisms responsible for these regulations suggest new potential therapeutic targets to be considered in the development of new inflammatory pain treatment.
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EXPERIMENTAL PROCEDURES

Sensory Neuron Primary Cultures and Semiquantitative RT-PCR
Experiments-Sensory neuron cultures were prepared from 5-8-weekold Wistar rat DRG as described previously (9) and were treated 24 h later either with NGF (100 ng/ml, Sigma) or with an anti-NGF antibody (1:1000, Sigma). Cells were harvested after 15, 30, 60, 120, and 240 min of treatment, and total RNA was prepared. For ontogenesis experiments, Wistar rat were sacrificed at various development stages, DRG isolated, and total RNA prepared (experiments have been repeated twice). Semiquantitative RT-PCR experiments were performed as described previously (9) . NGF primers were designed from rat NGFb (accession number XM_227525): forward, 5Ј-CAGAACCGTACACA-GATAGCA and reverse, 5Ј-GTGGTGCAGTATGAGTTCCAG. Statistical analysis was performed with Origin41.
Promoter Deletions-Deletions from the 5Ј end of construct 3/2925 (the full-length promoter, accession number AF527175) were realized either by PCR using LA Taq polymerase (Takara Biomedicals) or by 5Ј deletion using exonuclease III/mung bean enzymes (Promega, Madison, WI). For PCR experiments, the same reverse oligonucleotide was used for each construct: 5Ј-AGTGAAGACCGAGTAGGGCAC. Forward oligonucleotides were designed along the distal domain of construct 3/2925: 5Ј-GGAGACCCCAACCAGTAGCTA for construct 3/2110, 5Ј-GCCTG-GCTTTCCCAGCCCCTC for construct 3/2073, 5Ј-TGAGTACACTG-TAGCTGTCTT for construct 3/1985, and 5Ј-GGCATCGGATTCCATTA-CAGA for construct 3/1948 . Constructs 3/2276 and 3/1572 were realized by exonucleaseIII/mung bean experiments from construct 3/2925. The deleted sequences were subcloned in pBLUE TOPO (Invitrogen, The Netherlands) containing the ␤-galactosidase gene as a reporter gene. In silico analysis of DNA sequences was performed with Matinspector (35) and TESS (Transcription Element Search Software). 2 Transfection and Reporter Gene Activity Measurements-Transient transfection of 1-day-old primary cultures of DRG cells from 5-8-weekold Wistar rats was performed with Exgen 500 (Euromedex), according to the supplier's protocol. This transfection procedure was chosen for its high efficiency and lack of toxicity; reporter gene activity was measured, and the amounts of cell proteins measured were comparable in control versus transfected DRG cells. Each recombinant pBlue-TOPO vector was cotransfected with a pSEAP2 vector containing the gene coding for the secreted alkaline phosphatase (SEAP) under control of a constitutive promoter (Clontech, Palo Alto, CA). After transfection, the cells were either kept in normal medium or treated for 24 h with different inhibitors of signal transduction: SP600125 (10 M, Biomol, Plymouth Meeting, PA), PD98059 (10 M, Biomol), SB202190 (10 M, Calbiochem), U-73122 (25 M, Biomol), chelerythrine (10 M, Sigma), trichostatin A (1 M, Sigma), aspirin (5 mM, Sigma), salicylic acid (20 mM, Sigma), p75 antibody (2 g/ml, Sigma, clone ME 20.4), trkA antibody (2 g/ml, Abcam, reference ab8871). A pretreatment of 1 h was performed with the inhibitor or the antibody before NGF was added when required. ␤-Galactosidase and SEAP activities were measured as previously described (9) 24 h after transfection and treatment (14 h for aspirin). The measures were realized with a BioOrbit 1253 luminometer (Turku, Findland). For each sample, the ␤-galactosidase activity (i.e. the promoter construct transcriptional activity) was normalized with the SEAP activity (i.e. the transfection yield) and the amount of proteins (measured with Bio-Rad protein assay, Bio-Rad). The background level was measured with the ␤-galactosidase vector with no added promoter sequence. Statistical analysis was performed with Origin41. Comparisons of the means were done using Student's t test, and values were considered significantly different for p Յ 0.05. Even if the use of the different inhibitors may affect the expression of other genes sharing the same regulation pathways, the observation that some constructs do not respond to particular inhibitors while others do under the same conditions shows the signal specificity measured through the reporter gene activity.
RESULTS
Signaling Pathways Leading to Basal Expression of ASIC3 in Sensory Neurons by Low Endogenous NGF
We had previously shown that ASIC3 encoding gene promoter could be divided in three distinct functional regions ( neuron primary cultures with different constructs of ASIC3 encoding gene promoter (Fig. 1A ) and tested the effect of various inhibitors of the NGF signaling pathways (Fig. 1B) . Primary cultures of DRG neurons were used in all this study as (i) they are the most representative of what happens in these cells in vivo, and (ii) they have the specific intracellular pathways needed for ASIC3 expression and regulation of expression. Indeed, we have previously shown that about half of this population of neurons expresses functional ASIC3 current and that this current is increased in an inflammatory situation as observed in vivo (8, 9) .
The High Transcriptional Activity of the Proximal Domain Depends on MEK1 Activation- Fig. 2A shows the effect of inhibitors of the NGF signaling pathway on the basal transcriptional activity of construct 3/1066, which only contains the proximal domain of the promoter. As shown previously (8) , construct 3/1066 displays a transcriptional activity of 4.0 Ϯ 0.6-fold the background activity in normal conditions. A treatment with an inhibitor of MAPK/extracellular signal-regulated kinase kinase 1 (MEK1) activation (PD98059) (36, 37) reduced its transcriptional activity close to the background level (1.7 Ϯ 0.4, p ϭ 0.03). Treatments with U-73122, an inhibitor of the phospholipase C (PLC) activity (38) , chelerythrine, an inhibitor of the protein kinase C (PKC) activity (39), SB202190, an inhibitor of the p38 mitogen-activated protein kinase (p38MAPK) activation (40) , and SP600125, an inhibitor of cJun N-terminal kinases (JNKs) (41) did not significantly change the proximal promoter activity.
The Transcriptional Inhibition of the Proximal Domain Is Dependent upon Histone Deacetylase Activity-Histone deacetylases (HDACs) are widely expressed inhibitors of transcription recruited at the DNA level by DNA-binding factors such as transcription factors. This deacetylation increases the compaction degree of chromatin preventing the access to transcription activators (42) . As transfected DNA rapidely adopts a chromatin-like structure (43), we were able to study HDAC participation on the regulation of the ASIC3 transcription. As shown in 
4).
Perinatal Induction of ASIC3 Transcription Parallels NGF Transcription-The expression level of NGF is regulated at different stages of embryonic and postnatal development, and NGF protein levels parallel NGF mRNA levels (47, 48) . Fig. 3A shows that during development the ASIC3 mRNA level follows the NGFb mRNA level in DRG with a correlation coefficient of 0.85. Both expressions increased transiently perinatally. Fig. 3B shows that in mature sensory neurons, a high NGF concentration up-regulated ASIC3 mRNA expression within 30 min. Conversely, when an anti-NGF antiboby was applied to deplete the endogenous NGF present in the serum and produced by cells in culture, the level of ASIC3 transcript fell down to the detection level in 1-2 h.
DNA Sites Involved in ASIC3 Encoding Gene Regulation
We had shown previously that the main activating promoter area responsible for the expression of ASIC3 encoding gene in vivo is the distal domain of the promoter (Ϫ1673/Ϫ3174) (8) . To isolate the discrete sequences involved in the basal expression of the ASIC3 encoding gene and its induction by NGF, we generated six deletions from the 5Ј end of the full-length construct 3/2925: construct 3/2276 (construct 3/2925 with a 649 -FIG. 3. A, ASIC3 transcript level (q) and NGF transcript level (E) measured by semiquantitative RT-PCR in DRG from embryos and newborn rats. E ϭ embryonic day, and P ϭ postnatal day. Results are given as the ratio with the actin level measured in the same sample. B, ASIC3 transcript levels measured by semiquantitative RT-PCR in mature sensory neuron primary cultures either in absence of NGF (using an anti-NGF antibody, f) or in presence of high NGF concentration (E). ASIC3 mRNA levels are normalized with the actin transcript level assessed in the same sample. Results (mean Ϯ S.E.) are given as the ratio of ASIC3 mRNA level in treated conditions out of the normal condition level. n ϭ 3-6 for each experiment.
nucleotide-long deletion), construct 3/2115, construct 3/2073, construct 3/1985, construct 3/1948, and construct 3/1572. Fig. 4 shows the transcriptional activities of these different constructs in both normal and high NGF. Constructs 3/2276 and 3/2115 behaved like the full-length sequence. The situation was different for constructs 3/2073 and 3/1985, which did not respond to high NGF. Thus, the 42-nt-long sequence in position Ϫ2365/Ϫ2323 is critical for the induction of transcription by NGF. In silico analysis reveals that this short sequence is an activator protein 1-activator protein 1-E-box (AP1-AP1-E-box) string of response elements. The shorter constructs 3/1948 and 3/1572 were not able to drive any transcriptional activity. This demonstrates that the 37-nt-long sequence in position Ϫ2235/ Ϫ2198 is necessary for the basal expression of ASIC3 in sensory neurons. In silico analysis indicates the presence of a unique transcription factor 11/musculoaponeurotic fibrosarcoma transcription factor G (TCF11/MafG) response element.
DISCUSSION
Inflammation induces expression changes of ion channels, receptors, and neuropeptides in DRG neurons (9, 49 -51) . We have shown previously that during inflammation ASIC-like current densities, and particularly ASIC3-like currents, are increased in DRG neurons and that an increased number of neurons expresses this current type. These elevated levels of ASIC channel activity highly sensitize neurons to extracellular acidosis by producing hyperexcitability, the basis of hyperalgesia (8) . NGF is a key mediator in driving inflammatory sensitization of peripheral sensory neurons and is the main proinflammatory factor controlling ASIC3 expression level (8) . In the present work, we have identified the signal transduction pathways that control ASIC3 expression induction by NGF in normal and inflammatory conditions.
Control of ASIC3 Basal Expression in Sensory Neurons
The ASIC3 encoding gene promoter can be divided into three functional areas: a proximal domain, a middle repressive domain, and a distal activating domain (8) . In sensory neuron cultures, the proximal domain alone is able to drive a high expression of ASIC3 encoding gene that depends on NGF. We now show that the activity of the proximal domain is significantly reduced when MEK1 is inhibited. Downstream from the NGF/MEK-1 cascade, transcription factors can bind to this proximal domain turning on the transcription from the efficient CAAT box (Ϫ405/Ϫ416). This activity is inhibited by a repressive domain located on the 5Ј side. When the two domains are present, the transcription of the ASIC3 encoding gene is completely repressed. In this situation, the inhibition of HDACs allows the proximal domain to recover a transcriptional activity close to normal. The inhibition of the proximal domain thus includes a higher degree of chromatin condensation that probably closes the access to DNA to the MEK1-dependent transcription factors.
The activity of the full-length promoter, i.e. when the distal domain is present in 5Ј, is 2-fold the background activity whether HDACs are inhibited or not and does not reach the 4-fold activity of the proximal domain alone. The full-length promoter construct lacking the middle domain is not affected by HDAC inhibition and displays the high transcriptional activity of the full-length promoter construct under NGF stimulation. The middle domain is thus at least responsible for two different, independent repressive mechanisms. One is HDACdependent and acts only on the proximal domain, the other is HDAC-independent and acts on the distal domain. The HDACrepressive action may not affect the CAAT box area as the full-length promoter can work without HDAC inhibition.
ASIC3 basal expression strongly depends on the constitutive activation of trkA, the NGF-specific receptor, followed by the activation of the PLC/PKC pathway. At the promoter level, this activation relates to a specific 37-nt-long DNA sequence (Ϫ2235/Ϫ2198) along the distal domain that contains a unique TCF11/MafG heterodimer response element belonging to the AP1 subclass response element family. Maf and TCF11 proteins are widely expressed bZip transcription factors that can heterodimerize and play important roles in development and cell differentiation (52) . In sensory neurons, NGF maintains the phenotype of nociceptors (2), especially their chemical sensitivity (53) . We propose that a PKC pathway acting on a DRG-specific combination of transcription factors that could include TCF11 and MafG controls both the basal expression of ASIC3 and the DRG-specificity of ASIC3.
ASIC3 Encoding Gene Transcription and NGF Increase
ASIC3 and NGF Are Induced during Development-NGF expression is high during development (47) . It helps peripheral tissue innervation and neuronal specification of nociceptive fibers (54, 55) . During this time, NGF up-regulates genes like the preprotachykinin A gene (56) . We now show that in the perinatal period a high expression of NGF is also associated with a high level of expression of ASIC3. This ASIC3 mRNA increase correlates with the detection of ASIC3-like currents in DRG during the early postnatal period (19, 57) and the prenatal development. 
ASIC3 mRNA Level Is Regulated by Inflammatory NGF-
Intradermal injections of NGF produce rapid hyperalgesia in rats (58, 59) . During peripheral inflammation, various cell types from the skin and those that are locally accumulated (e.g. mast cells and neutrophiles) elevate NGF concentration (59) . Following inflammation, ASIC3 expression level increases and contributes to an increased neuron hyperexcitability (8) . It is known that transcriptional changes induced by NGF appear within the first hours (58) , either inducing the expression of FIG. 4 . Transcriptional activities of the promoter constructs corresponding to serial 5 deletions of the distal domain. ␤-Galactosidase activity is measured in normal condition (white bars) and after a 24-h treatment with NGF (black bars). Results are normalized and given as described in figure 1 . ૺ corresponds to a significant difference (p Յ 0.05) with the basal activity of construct 3/2925; ૾ corresponds to a significant difference (p Յ 0.05) with the NGF-induced expression of construct 3/2925, n ϭ 3-6 for each experiment.
immediate early genes such as c-fos/c-jun or activating some constitutive transcription factors already present in the nucleus, such as ATFs (activating transcription factors). For example, c-Fos can be induced within the first 30 min after the extracellular signal occurs (e.g. NGF, cytokines, or stress) (60). These induced transcription factors then activate the expression of genes like calcitonin gene-related peptide and preprotachykinin A genes that are up-regulated by NGF within 12 h (5). As we show that the time course induction of ASIC3 mRNA is around 30 min, this induction does probably not involve the induction of immediate early genes. Factors that participate in ASIC3 induction such as c-Jun are indeed constitutively expressed in DRG cultures. This induction is reversible as ASIC3 expression level quickly decreases when NGF is removed. This last observation can be correlated to the previous observation that a lack of NGF produces a reversible loss of the sustained pH-induced current of adult DRG neurons (53) .
ASIC3 Encoding Gene Regulation Implicates Different Signaling Pathways and Different Promoter Response Elements-
ASIC3 transcription increases during inflammation because of high NGF (8) . Our results now show that this involves the combined activation of the stress-activated kinases JNKs and p38MAPK. High concentrations of NGF cannot rescue a transcriptional activity from the ASIC3 encoding gene promoter when the PLC/PKC system is inhibited. The transcriptional cooperation of the JNK/p38MAPK system is then a reinforcement of the prior action of the PLC/PKC-dependent transcription factors. In normal conditions trkA sufficiently activates JNKs and p38MAPK, but as their downstream transcriptional action is inhibited, transcription of ASIC3 cannot be induced. The removal of this inhibition and the subsequent ASIC3 overexpression depend on the activation of p75, the nonspecific neurotrophin receptor, by NGF at higher concentration. The concomitant activation of both pathways (trkA and p75) is thus necessary for the overexpression of ASIC3.
The action of JNK/p38MAPK is specifically dependent on a 42-nt-long DNA sequence (Ϫ2365/Ϫ2323) along the distal domain of the promoter. Analysis of this sequence targeted by stress-activated kinases reveals the presence of an AP1-AP1-E-box string of response elements that can be bound by c-Jun and/or ATFs and upstream stimulatory factors. A similar string of response elements is also present in the promoter of the preprotachykinin A gene (61) . However, while AP1 sites bind to the immediate early factor c-Fos in the preprotachykinin A case (62) , the phosphorylation of c-Jun and p38MAPK-dependent phosphorylation of ATF2 regulate ASIC3 expression. These factors are present in cultured sensory neurons (63) and can be phosphorylated downstream the NGF signal (64, 65) . Then, in sensory neurons either c-Jun and/or ATF2 could form homo-and/or heterodimers that could bind to AP1 sites in position Ϫ2365/Ϫ2323 to regulate ASIC3 expression. JNKs/cJun and p38MAPK/ATF2 are also expressed during perinatal time (66, 67) , and this can explain why inflammation reproduces the developmental situation in ASIC3 expression. Aspirin or salicylic acid act on signaling pathways that target the distal domain of ASIC3 encoding gene promoter. It is known that salicylates inhibit MAPKs, JNKs, and AP1 and activate p38MAPK (68) . We then propose that salicylate drugs unbalance the combined action of JNKs and p38MAPK and/or may directly inhibit the function of c-Jun.
Conclusions
This work describes the way NGF tightly controls the expression of the ASIC3 encoding gene in sensory neurons. In physiological situation, low endogenous NGF activates via trkA the PLC/PKC pathway. This leads to the activation of transcription factors that bind to a TCF11/MafG response element along the distal domain of the ASIC3 encoding gene promoter. NGF also activates JNK and p38MAPK pathways, but their downstream activating effect is inhibited at the transcriptional level by repressors present on the middle repressive domain of the promoter. During inflammation, the increase in NGF concentration removes this transcriptional inhibition via p75 allowing thus the JNK/p38MAPK system to enhance ASIC3 encoding gene transcription via AP1 response elements present on the distal domain of the promoter. Fig. 5 proposes a putative model FIG. 5 . Model for the control of the ASIC3 encoding gene transcription in sensory neurons. A, ASIC3 basal expression. Basal NGF involves the trkA/PLC/PKC pathway, which activates a specific combination of transcription factors that could be a TCF11-MafG heterodimer. Once activated, this dimer binds to its specific corresponding response element (T/M RE) along the distal domain of ASIC3 encoding gene promoter and turns on basal transcription. This latter action certainly happens by facilitating the binding of general transcription factors (GTFs) on the non-consensus CAAT box (Ϫ405/Ϫ416) close to the transcription start site (Ϫ343). Indeed, the presence of the CAAT box region alone cannot initiate the transcription by itself (8) . Because the distance between the CAAT box and the TCF11/MafG response element involved along the distal domain is about 1.5 kb, proteinprotein interaction should occur via the formation of a DNA loop (79) . During this basal situation, the MEK1-dependent response element (MEK1-RE) on the proximal domain of the promoter is locked (hatched area) by HDACs recruited in 5Ј along the middle repressive domain. In parallel, JNKs and p38MAPK are active downstream trkA and involve at least c-Jun on an AP1-AP1-E-box string of response elements (AP1-RE) along the distal activating domain. However, this action is inhibited by repressors (R) bound to DNA sequences (RRE) in the middle repressive domain, acting either through competition (i.e. binding on a same response element) or through quenching (i.e. masking the activating domain of transcription factors already bound to their response element, as displayed in this figure) (80) . B, induction of ASIC3 expression in inflammation. NGF present at high concentration involves both trkA and p75. The activation of p75 serves as a transcriptional switch as it probably leads to changes in the transcriptional repressor conformation. Then, the JNK/p38MAPK-dependent factors acting on the AP1-RE are released, and the DNA loop is unwound. These latter factors, activated under trkA control, can thus reinforce the basal transcriptional system dependent on the PLC/PKC pathway and produce ASIC3 overexpression.
for the regulation of ASIC3 expression in sensory neurons. Once up-regulated, ASIC3 can trigger sensory neuron hyperexcitability, a condition that accounts for the onset and the maintenance of hyperalgesia responsible for clinical inflammatory pain. The blocking of ASIC activity and/or expression could thus be of a therapeutic relevance. Non-steroidal anti-inflammatory drugs are highly efficient in reducing inflammatory pain and hyperalgesia (69, 70) . They directly inhibit ASIC currents and also reduce ASIC encoding gene expression during inflammation (Ref . 9 and this work) . The present work also shows that SP600125, an anthrapyrazolone that reversibly inhibits JNK-dependent phosphorylation of c-Jun (41), can prevent inflammation-induced ASIC3 overexpression. This compound is presently on assessment as a new anti-inflammatory drug for rheumatoid arthritis treatment (71) . An inhibition of ASIC3 expression through the PLC/PKC pathway, a pathway that participates in the inflammation-induced expression regulation of different pro-inflammatory genes, could also probably lower the onset of neuronal hyperexcitability due to continuous acidic inflammatory stimulus and thus diminish the feeling of pain.
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